Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.11
- Piotroski Score 4.00
- Grade Buy
- Symbol (HROW)
- Company Harrow Health, Inc.
- Price $42.85
- Changes Percentage (-2.35%)
- Change -$1.03
- Day Low $42.74
- Day High $44.45
- Year High $59.23
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/13/2025
- Fiscal Year End N/A
- Average Stock Price Target $50.00
- High Stock Price Target $73.00
- Low Stock Price Target $25.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.91
- Trailing P/E Ratio -19.97
- Forward P/E Ratio -19.97
- P/E Growth -19.97
- Net Income $-24,411,000
Income Statement
Quarterly
Annual
Latest News of HROW
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
NYC migrant allegedly throws pal's beloved pit bull off 14th-floor...
A Brooklyn man was arrested for throwing a 2-year-old pit bull off a 14th-floor balcony, leaving the dog's owner devastated. The suspect, Alberto Morris, faces charges but was released due to non-bail...
By New York Post | 1 day ago -
'I just want it to end': Rock-throwing vandals cause $100K damage at B.C. auto dealership - BC | Globalnews.ca
An auto dealership owner in Abbotsford, B.C., offers $100,000 for info on a repeat vandal causing up to $12,000 in damages each time by hurling rocks at parked vehicles, particularly targeting Hondas....
By Global News | 1 day ago -
NASA Telescopes Watch 'Flame-Throwing Guitar' Rock Out In Space
A NASA collaboration captured the Guitar Nebula resembling a flame-throwing guitar in space. Data from Chandra X-ray Observatory and Hubble Space Telescope show a celestial instrument blasting particl...
By Forbes | 1 day ago
